Treating Seizures after Hypoxic-Ischemic Encephalopathy-Current Controversies and Future Directions

Area of Science:

• Neonatal neurology
• Neurocritical care
• Developmental neuroscience

Background:

• Seizures are frequent in newborns with hypoxic-ischemic encephalopathy (HIE), correlating with poor neurodevelopmental outcomes.
• The precise impact of seizure activity on brain development and optimal management strategies, especially with therapeutic hypothermia, remain poorly understood.
• It is unclear if seizures worsen brain injury or simply indicate evolving damage.

Purpose of the Study:

• To review the current understanding of neonatal seizures in HIE.
• To evaluate the efficacy and safety of anticonvulsant therapies in the context of therapeutic hypothermia.
• To identify knowledge gaps and guide future research directions.

Main Methods:

• Literature review of existing studies on neonatal seizures, HIE, and anticonvulsant treatments.
• Analysis of preclinical data on the neurotoxic effects of anticonvulsants.
• Examination of the role of therapeutic hypothermia in seizure management.

Main Results:

• Established anticonvulsants like phenobarbital and phenytoin show limited efficacy and potential neurotoxicity in developing brains.
• Levetiracetam may have fewer neurotoxic effects but its efficacy is uncertain.
• Therapeutic hypothermia possesses intrinsic anticonvulsant properties, complicating the assessment of additional drug therapies.

Conclusions:

• High-quality evidence is lacking regarding the extent to which neonatal seizures exacerbate HIE-related brain damage and the best management strategies.
• Randomized controlled trials are essential to determine the safety and efficacy of anticonvulsants used concurrently with therapeutic hypothermia.
• Further research is needed to clarify the role and optimal timing of prophylactic anticonvulsant administration, such as phenobarbital, in improving neurodevelopmental outcomes.